HUP0302790A3 - Novel receptors for si(helicobacter pylori) and use thereof - Google Patents

Novel receptors for si(helicobacter pylori) and use thereof

Info

Publication number
HUP0302790A3
HUP0302790A3 HU0302790A HUP0302790A HUP0302790A3 HU P0302790 A3 HUP0302790 A3 HU P0302790A3 HU 0302790 A HU0302790 A HU 0302790A HU P0302790 A HUP0302790 A HU P0302790A HU P0302790 A3 HUP0302790 A3 HU P0302790A3
Authority
HU
Hungary
Prior art keywords
helicobacter pylori
novel receptors
receptors
novel
pylori
Prior art date
Application number
HU0302790A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Biotie Therapies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corp filed Critical Biotie Therapies Corp
Publication of HUP0302790A2 publication Critical patent/HUP0302790A2/hu
Publication of HUP0302790A3 publication Critical patent/HUP0302790A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HU0302790A 2001-01-19 2002-01-18 Novel receptors for si(helicobacter pylori) and use thereof HUP0302790A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010118A FI20010118A7 (fi) 2001-01-19 2001-01-19 Uudet helicobacter pylori reseptorit ja niiden käyttö
PCT/FI2002/000043 WO2002056893A1 (en) 2001-01-19 2002-01-18 Novel receptors for $i(helicobacter pylori) and use thereof

Publications (2)

Publication Number Publication Date
HUP0302790A2 HUP0302790A2 (hu) 2003-11-28
HUP0302790A3 true HUP0302790A3 (en) 2010-01-28

Family

ID=8560066

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0302790A HUP0302790A3 (en) 2001-01-19 2002-01-18 Novel receptors for si(helicobacter pylori) and use thereof

Country Status (19)

Country Link
US (1) US20040096465A1 (enExample)
EP (1) EP1359922A1 (enExample)
JP (1) JP2004519459A (enExample)
KR (1) KR100886777B1 (enExample)
CN (1) CN100455290C (enExample)
AU (1) AU2002229792B2 (enExample)
CA (1) CA2434350A1 (enExample)
CZ (1) CZ20031914A3 (enExample)
EE (1) EE200300339A (enExample)
FI (1) FI20010118A7 (enExample)
HU (1) HUP0302790A3 (enExample)
IL (1) IL156992A0 (enExample)
NO (1) NO20033270L (enExample)
NZ (1) NZ526906A (enExample)
PL (1) PL363617A1 (enExample)
RU (1) RU2306140C2 (enExample)
SK (1) SK10042003A3 (enExample)
WO (1) WO2002056893A1 (enExample)
ZA (1) ZA200305155B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20011671A7 (fi) 2001-08-20 2003-02-21 Carbion Oy Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
AU2003201619A1 (en) * 2002-01-18 2003-07-30 Biotie Therapies Corporation Novel binding epitopes for helicobacter pylori and use thereof
JP5219329B2 (ja) * 2002-06-28 2013-06-26 ネステク、リミテッド 下痢の予防又は治療用の医薬組成物
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
WO2004065400A1 (en) * 2003-01-20 2004-08-05 Glykos Finland Oy Novel binding epitopes for helicobacter pylori and use thereof
JP5035787B2 (ja) * 2005-10-04 2012-09-26 焼津水産化学工業株式会社 α−１、４結合型Ｎ−アセチルグルコサミン含有Ｏ−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤
JP5140246B2 (ja) * 2006-03-15 2013-02-06 公益財団法人野口研究所 Ｎ−アセチルグルコサミンの誘導体を含有するピロリ菌増殖抑制剤
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
US8075674B2 (en) 2006-11-30 2011-12-13 Donaldson Company, Inc. Filter apparatus with pulse cleaning and methods for pulse cleaning filters
EP2217246B1 (en) * 2007-11-08 2014-12-17 Nestec S.A. Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
JP5933106B2 (ja) * 2012-03-19 2016-06-08 マックス プランク ゲゼルシャフト ツゥアー フェデルゥン デル ヴィッセンシャフテン エー フォー 炭水化物−糖脂質共役ワクチン
PL2911676T3 (pl) * 2012-10-29 2020-12-28 The Board Of Trustees Of The University Of Arkansas Nowe adiuwanty śluzówkowe oraz systemy dostarczania
CN112023037A (zh) * 2020-09-09 2020-12-04 四川大学 一种聚糖在制备对Hp感染的预防和治疗产品中的应用、产品及制备方法
CN112285338B (zh) * 2020-10-20 2023-04-28 四川大学华西医院 一种copd诊断试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
SE8203925D0 (sv) 1982-06-23 1982-06-23 Svenska Sockerfabriks Ab New and novel glycosides, glycoconjugates and processes for their preparation
DK17685D0 (da) * 1985-01-14 1985-01-14 Hans Goeran Magnusson Glycosidderivater
US5217715A (en) * 1988-08-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Carbohydrate receptor for bacteria and method for use thereof
KR960022566A (ko) * 1994-12-30 1996-07-18 김충환 신규한 아미노올리고당 유도체 및 그의 제조방법
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof

Also Published As

Publication number Publication date
ZA200305155B (en) 2004-07-19
JP2004519459A (ja) 2004-07-02
WO2002056893A1 (en) 2002-07-25
NO20033270D0 (no) 2003-07-18
IL156992A0 (en) 2004-02-08
CN100455290C (zh) 2009-01-28
RU2003125370A (ru) 2005-02-10
CA2434350A1 (en) 2002-07-25
CN1525862A (zh) 2004-09-01
FI20010118L (fi) 2002-07-20
SK10042003A3 (sk) 2003-11-04
RU2306140C2 (ru) 2007-09-20
EP1359922A1 (en) 2003-11-12
FI20010118A0 (fi) 2001-01-19
AU2002229792B2 (en) 2007-08-16
NZ526906A (en) 2005-03-24
EE200300339A (et) 2003-10-15
NO20033270L (no) 2003-09-19
HUP0302790A2 (hu) 2003-11-28
KR100886777B1 (ko) 2009-03-04
PL363617A1 (pl) 2004-11-29
US20040096465A1 (en) 2004-05-20
CZ20031914A3 (cs) 2004-04-14
FI20010118A7 (fi) 2002-07-20
KR20040018329A (ko) 2004-03-03
WO2002056893A8 (en) 2003-11-13

Similar Documents

Publication Publication Date Title
GB2394014B (en) Turbocharger apparatus
HUP0302790A3 (en) Novel receptors for si(helicobacter pylori) and use thereof
AU2003276307A1 (en) High affinity receptors for helicobacter pylori and use thereof
GB0017239D0 (en) Detection of helicobacter pylori
GB2381581B (en) Sampling device
GB0213962D0 (en) Coupling device
AU2003201619A1 (en) Novel binding epitopes for helicobacter pylori and use thereof
GB2408779B (en) Turbocharger apparatus
GB2371840B (en) Coupling device
GB0129683D0 (en) Sampling device
GB0017149D0 (en) Helicobacter pylori mutants
GB0010371D0 (en) Helicobacter pylori antigens
GB0128003D0 (en) Marking out device
GB2383314B (en) Connecting device
TW516382U (en) Improved aquiculture device
GB2384828B (en) Sampling device
GB0121208D0 (en) Helicobacter pylori vaccines
GB0010370D0 (en) Helicobacter pylori antigens
AU4789400A (en) (helicobacter pylori) antigens
GB2383317B (en) Mooring device
AU2002328123A1 (en) Helicobacter pylori vaccination
TW493609U (en) Moving and carrying device
CA92345S (en) Carrying device
TW573750U (en) Carrying device
TW519356U (en) Carrying apparatus

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees